Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vertex Pharmaceuticals (VRTX) closed at $428 in the latest trading session, marking a +0.03% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.61%.

Removing rumored games from the equation, as well as unconfirmed games in general, you are left with just eight confirmed Nintendo Switch 2 games. This is at least the case as of January 19 ...

The Nintendo Switch 2 will be a direct follow-up to what is likely Nintendo’s most successful console of all time when it releases later this year. Only one problem though… we don’t know the ...

After years of speculation around what it could look like, this week Nintendo officially revealed the successor to its most popular home console ever: the Nintendo Switch 2. The new device looks a ...

Here's why they think Eli Lilly (NYSE: LLY), Intuitive Surgical (NASDAQ: ISRG), and Vertex Pharmaceuticals (NASDAQ: VRTX) are unstoppable stocks to buy in 2025. Where to invest $1,000 right now?